Crossmark

Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells

Published Online: 2016-12-20

Published Print: 2016-12

Authors

Kilinc, Mehmet Okyay

Ehrig, Klaas

Pessian, Maysam

Minev, Boris R.

Szalay, Aladar A.
Funding

Funding for this research was provided by:

National Institutes of Health (RO1CA154256)
License Information

Text and Data Mining valid from 2016-12-01

Version of Record valid from 2016-12-20
More Information

Article History

Received: 3 October 2016

Accepted: 24 November 2016

First Online: 20 December 2016

Document is current